---
schema_version: "secwatch.filing_event.v1"
accession: "0001663577-25-000317"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:42:24.937392+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Bio-Path warns of going concern doubt, seeks financing; director resigns

## Summary
- Director Douglas Morris resigned effective Nov 13, 2025; resignation received Nov 4.
- Company seeking financing to fund turnaround; plans to update finance team, engage new PCAOB auditors, hire investment bankers to review biotech portfolio for sale/partnership/M&A.
- Warns substantial doubt about ability to continue as going concern if capital raise fails; notes risk of delisting from OTC Markets.
- No specifics on financing amount or timeline; strategic review of portfolio and M&A pursuits announced.

## SEC filing metadata
- accession: 0001663577-25-000317
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/0001663577-25-000317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/bpth_8k110425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001663577-25-000317
- JSON: https://secwatch.observer/filing/0001663577-25-000317.json
- Plain text: https://secwatch.observer/filing/0001663577-25-000317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.